Computational biologist with extensive experience in multi-omics analysis to investigate complex diseases, including Alzheimer’s disease and colorectal, lung, and skin cancers. At Columbia University, leading glycoproteomic studies to uncover the role of glycosylation in neurodegeneration using LC-MS/MS data and advanced methods such as QTL mapping, TWAS, and colocalization. Skilled in machine learning and mathematical modeling for studying drug resistance and therapeutic response. Bringing expertise in statistical genetics, systems biology, and molecular network analysis to uncover mechanisms underlying complex diseases.
Selected Projects:
Worked on Formal modeling of gene regulatory networks
The contributions to glycoproteomic research at Columbia have been presented at: